Дата випуску | Назва | Автор(и) |
2021 | A potential role of fecal oxalate-degrading activity in oxalate homeostasis in end-stage renal disease patients; a descriptive pilot study | Stepanova, N.; Tolstanova, G.; Korol, L.; Akulenko, I.; Savchenko, O.; Kolesnyk, M. |
2018 | Antioxidant effects of immunomodulators in patients with recurrent pyelonephritis | Kolesnyk, M.; Korol, L.; Stepanova, N.; Driianska, V.; Migal, L.; Savchenko, V. |
2019-03 | Can hyperoxaluria cause kidney damage in women with recurrent pyelonephritis? | Stepanova, N.; Kolesnyk, M.; Driianska, V.; Korol, L. |
2021 | Could the residual renal function remain a key determinant of plasma oxalic acid concentration in peritoneal dialysis patients? | Stepanova, N.; Korol, L.; Snisar, L.; Lebid, L. |
2019 | Extracellular overhydration in peritoneal dialysis patients linked with increased oxidative stress | Stepanova, N.; Korol, L.; Burdeyna, O.; Kolesnyk, M. |
2022 | Low Oxalate-Degrading Activity in Fecal Microbiota is Associated With High Serum Indoxyl Sulfate and Plasma Oxalic Acid Concentrations in Dialysis Patients | Stepanova, N.; Korol, L.; Tolstanova, G.; Akulenko, I. |
2022 | Oxalate Balance in Peritoneal Dialysis Patients: A Potential Role of Dialysis-related Peritonitis | Stepanova, N.; Korol, L.; Lebid, L.; Snisar, L.; Savchenko, S. |
2019 | Oxidative status in hemodialysis patients with erythropoietin hyporesponsiveness anemia | Korol, L.; Stepanova, N.; Novakisksiy, V.; Shifris, I.; Migal, L. |
2019 | Oxidative stress in peritoneal dialysis patients: association with the dialysis adequacy and technique survival | Stepanova, N.; Korol, L.; Burdeyna, O. |
2021 | Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study | Stepanova, N.; Driianska, V.; Korol, L.; Snisar, L.; Lebed, L. |
2020 | Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study | Stepanova, N.; Driianska, V.; Korol, L.; Snisar, L.; Lebed, L. |
2020 | Regulation of oxalate homeostasis by oxalate-degrading activity in fecal microbiota in dialysis patients | Stepanova, N.; Tolstanova, G.; Akulenko, I.; Korol, L.; Savchenko, O.; Snisar, L.; Kolesnyk, M. |
2020 | Serum paraoxonase 1 arylesterase activity as an antioxidant marker in dialysis patients | Korol, L.; Stepanova, N.; Vasylchenko, V. |
2022 | Serum total indoxyl sulfate is associated with intraperitoneal inflammation and high peritonitis episodes in peritoneal dialysis patients | Stepanova, N.; Korol, L.; Driianska, V.; Snisar, L.; Lebid, L.; Kompaniets, O. |
2018 | The relationship between the dose of continuous erythropoietin receptor activator and oxidative stress in hemodialysis patients | Stepanova, N.; Korol, L.; Novakivskyy, V.; Kolesnyk, M. |